ACCLX | MVCAX | ACCLX / MVCAX | |
Total Expense Ratio | 1.98 | 0.99 | 200% |
Annual Report Gross Expense Ratio | 1.98 | 1.00 | 198% |
Fund Existence | 15 years | 24 years | - |
Gain YTD | 5.502 | 3.944 | 140% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.05B | 17.2B | 41% |
Annual Yield % from dividends | 0.65 | 0.87 | 74% |
Returns for 1 year | 1.43 | -2.05 | -70% |
Returns for 3 years | 4.83 | 16.77 | 29% |
Returns for 5 years | 13.23 | 54.78 | 24% |
Returns for 10 years | 4.60 | 68.52 | 7% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 67.29 | 1.21 | +1.83% |
Janus Henderson Global Life Sciences D | |||
RGABX | 74.69 | 0.70 | +0.95% |
American Funds Growth Fund of Amer R2 | |||
MPEGX | 26.55 | N/A | N/A |
Morgan Stanley Inst Discovery I | |||
GSRAX | 11.60 | N/A | N/A |
Goldman Sachs Rising Dividend Gr A | |||
KMDIX | 31.15 | N/A | N/A |
Keeley Gabelli Mid Cap Dividend I |